Ophthalmic disease

INDICATION: Choroidal neovascularization (CNV); ophthalmic

Mouse studies suggest a cell-permeable CAV1-based fusion peptide could help treat CNV and retinal neovascularization. In

Read the full 201 word article

How to gain access

Continue reading with a
two-week free trial.